Burkitt's Lymphoma in a Patient with Adenosine Deaminase Deficiency-Severe Combined Immunodeficiency Treated with Polyethylene Glycol-Adenosine Deaminase

Maitham Husain; Eyal Grunebaum; Ahmed Naqvi; Adelle Atkinson; Bo Y. Ngan; Alessandro Aiuti; Chaim M. Roifman

doi:10.1016/j.jpeds.2007.03.059

Burkitt's Lymphoma in a Patient with Adenosine Deaminase Deficiency-Severe Combined Immunodeficiency Treated with Polyethylene Glycol-Adenosine Deaminase

Maitham Husain, Eyal Grunebaum, Ahmed Naqvi, Adelle Atkinson, Bo Y. Ngan, Alessandro Aiuti, Chaim M. Roifman

IRCCS Ospedale San Raffaele

Research output: Contribution to journal › Article

Abstract

We describe a patient with severe combined immunodeficiency because of aberrations in adenosine deaminase (ADA) who despite adequate replacement with polyethylene glycol-linked ADA (PEG-ADA) for 13 years developed Burkitt's lymphoma. Although treatment corrected the metabolic abnormalities caused by ADA deficiency, it failed to fully restore cellular immunity.

Original language	English
Pages (from-to)	93-95
Number of pages	3
Journal	Journal of Pediatrics
Volume	151
Issue number	1
DOIs	https://doi.org/10.1016/j.jpeds.2007.03.059
Publication status	Published - Jul 2007

ASJC Scopus subject areas

Pediatrics, Perinatology, and Child Health

Access to Document

10.1016/j.jpeds.2007.03.059

Fingerprint Dive into the research topics of 'Burkitt's Lymphoma in a Patient with Adenosine Deaminase Deficiency-Severe Combined Immunodeficiency Treated with Polyethylene Glycol-Adenosine Deaminase'. Together they form a unique fingerprint.

Cite this

Husain, M., Grunebaum, E., Naqvi, A., Atkinson, A., Ngan, B. Y., Aiuti, A., & Roifman, C. M. (2007). Burkitt's Lymphoma in a Patient with Adenosine Deaminase Deficiency-Severe Combined Immunodeficiency Treated with Polyethylene Glycol-Adenosine Deaminase. Journal of Pediatrics, 151(1), 93-95. https://doi.org/10.1016/j.jpeds.2007.03.059

Burkitt's Lymphoma in a Patient with Adenosine Deaminase Deficiency-Severe Combined Immunodeficiency Treated with Polyethylene Glycol-Adenosine Deaminase. / Husain, Maitham; Grunebaum, Eyal; Naqvi, Ahmed; Atkinson, Adelle; Ngan, Bo Y.; Aiuti, Alessandro; Roifman, Chaim M.

In: Journal of Pediatrics, Vol. 151, No. 1, 07.2007, p. 93-95.

Research output: Contribution to journal › Article

@article{b983e5133947405cb35cd294f2d2a585,

title = "Burkitt's Lymphoma in a Patient with Adenosine Deaminase Deficiency-Severe Combined Immunodeficiency Treated with Polyethylene Glycol-Adenosine Deaminase",

abstract = "We describe a patient with severe combined immunodeficiency because of aberrations in adenosine deaminase (ADA) who despite adequate replacement with polyethylene glycol-linked ADA (PEG-ADA) for 13 years developed Burkitt's lymphoma. Although treatment corrected the metabolic abnormalities caused by ADA deficiency, it failed to fully restore cellular immunity.",

author = "Maitham Husain and Eyal Grunebaum and Ahmed Naqvi and Adelle Atkinson and Ngan, {Bo Y.} and Alessandro Aiuti and Roifman, {Chaim M.}",

year = "2007",

month = jul,

doi = "10.1016/j.jpeds.2007.03.059",

language = "English",

volume = "151",

pages = "93--95",

journal = "Journal of Pediatrics",

issn = "0022-3476",

publisher = "Mosby Inc.",

number = "1",

}

TY - JOUR

T1 - Burkitt's Lymphoma in a Patient with Adenosine Deaminase Deficiency-Severe Combined Immunodeficiency Treated with Polyethylene Glycol-Adenosine Deaminase

AU - Husain, Maitham

AU - Grunebaum, Eyal

AU - Naqvi, Ahmed

AU - Atkinson, Adelle

AU - Ngan, Bo Y.

AU - Aiuti, Alessandro

AU - Roifman, Chaim M.

PY - 2007/7

Y1 - 2007/7

N2 - We describe a patient with severe combined immunodeficiency because of aberrations in adenosine deaminase (ADA) who despite adequate replacement with polyethylene glycol-linked ADA (PEG-ADA) for 13 years developed Burkitt's lymphoma. Although treatment corrected the metabolic abnormalities caused by ADA deficiency, it failed to fully restore cellular immunity.

AB - We describe a patient with severe combined immunodeficiency because of aberrations in adenosine deaminase (ADA) who despite adequate replacement with polyethylene glycol-linked ADA (PEG-ADA) for 13 years developed Burkitt's lymphoma. Although treatment corrected the metabolic abnormalities caused by ADA deficiency, it failed to fully restore cellular immunity.

UR - http://www.scopus.com/inward/record.url?scp=34250679783&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34250679783&partnerID=8YFLogxK

U2 - 10.1016/j.jpeds.2007.03.059

DO - 10.1016/j.jpeds.2007.03.059

M3 - Article

C2 - 17586199

AN - SCOPUS:34250679783

VL - 151

SP - 93

EP - 95

JO - Journal of Pediatrics

JF - Journal of Pediatrics

SN - 0022-3476

IS - 1

ER -